SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-019044
Filing Date
2022-12-30
Accepted
2022-12-30 16:01:20
Documents
15
Period of Report
2022-12-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20221223x8k.htm   iXBRL 8-K 34678
2 EX-10.1 krbp-20221223xex10d1.htm EX-10.1 97011
3 GRAPHIC krbp-20221223xex10d1002.jpg GRAPHIC 6776
4 GRAPHIC krbp-20221223xex10d1003.jpg GRAPHIC 1382
  Complete submission text file 0001558370-22-019044.txt   283870

Data Files

Seq Description Document Type Size
5 EX-101.SCH krbp-20221223.xsd EX-101.SCH 3042
6 EX-101.LAB krbp-20221223_lab.xml EX-101.LAB 16580
7 EX-101.PRE krbp-20221223_pre.xml EX-101.PRE 10533
9 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20221223x8k_htm.xml XML 5077
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 221501982
SIC: 2836 Biological Products, (No Diagnostic Substances)